Key facts
- Gynius Plus’s last known valuation is $5.7M (Jan 2020).
- It has raised $420K; the latest was Seed Round in Apr 2025.
- Notable investors include SOSV, HAX.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Gynius Plus
- ·The full record, as it builds
Funding rounds
No funding rounds for Gynius Plus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gynius Plus
Developer of diagnostic imaging equipment designed for medical examination purposes. The company offers a portable, imaging device with real-time video capture, integrated data storage, and wireless connectivity, enabling healthcare professionals in clinical and remote settings to perform visual assessments, document findings, and facilitate collaboration.
- Sector
- Healthcare
- HQ
- Goteborg, Sweden
- Founded
- 2009
- Employees
- 13
- Website
- gynius.org/
- Ownership
- Privately Held (backing)
Gynius Plus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gynius Plus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gynius Plus in its N-PORT filings yet. We sweep new filings monthly.